Funding Archives - Page 2 of 6 -

Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it

Sidekick Health raises $20m to fund digital therapeutics expansion

https://pharmaphorum.com/news/sidekick-health-raises-20m-to-fund-digital-therapeutics-expansion/

News/ News/ R&D

SparingVision raises €44.5m for retinitis pigmentosa gene therapy

Richard Staines Funding, ophthalmology, Oxford Biomedica, R&D, Sanofi, SparingVision 0 Comment

French biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare

SparingVision raises €44.5m for retinitis pigmentosa gene therapy

https://pharmaphorum.com/news/sparingvision-raises-44-5-million-euros-for-retinitis-pigmentosa-gene-therapy/

Market Access/ News/ News/ News/ Patients/ Top stories

US snaps up first supplies of Regeneron’s COVID-19 antibody

Phil Taylor BARDA, coronavirus, coronavirus vaccine, Funding, infectious disease, Novavax, Regeneron, US 0 Comment

Hard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has

US snaps up first supplies of Regeneron’s COVID-19 antibody

https://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/

Stock brokers looking at computer screens, trading online.

News/ News/ News/ Oncology/ R&D

Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D

Richard Staines cancer, CAR T, Funding, IPO, multiple myeloma, Poseida Therapeutics, Prostate cancer 0 Comment

California biotech Poseida Therapeutics has become the latest biotech to hit the IPO trial after a string of launches last

Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D

https://pharmaphorum.com/news/poseida-therapeutics/

News/ News/ R&D

NodThera raises $55m in Series B round to trial inflammatory disease drugs

Richard Staines Biotech, Funding, inflammatory diseases, NodThera, pipeline, R&D 0 Comment

The Anglo-US biotech NodThera has raised $55 million in a second financing round as it prepares its inflammatory

NodThera raises $55m in Series B round to trial inflammatory disease drugs

https://pharmaphorum.com/news/nodthera-raises/

AI and cancer care: Three ways artificial intelligence may transform cancer outcomes

Digital/ News/ News/ News/ R&D

AI drug discovery firm Exscientia gets $60M cash injection

Phil Taylor artificial intelligence, drug discovery, exscientia, Funding, Novo Holdings 0 Comment

UK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round

AI drug discovery firm Exscientia gets $60M cash injection

https://pharmaphorum.com/news/ai-drug-discovery-firm-exscientia-gets-60m-cash-injection/

Market Access/ News/ News/ News/ R&D

US government gives Moderna $483m for COVID-19 vaccine

Phil Taylor coronavirus, coronavirus vaccine, Funding, Moderna, usa 0 Comment

The US government has agreed to provide a whopping $483 million in federal funding to propel Modera’s coronavirus

US government gives Moderna $483m for COVID-19 vaccine

https://pharmaphorum.com/news/us-government-gives-modernas-covid-19-vaccine-483m-backing/

News/ News/ Oncology

Cancer Research UK cuts research funding as COVID-19 hits income

Richard Staines cancer, Cancer Research UK, coronavirus, COVID-19, Funding, Oncology, R&D 0 Comment

Cancer Research UK has cut funding to its research activities, as the charity faces a cut to its

Cancer Research UK cuts research funding as COVID-19 hits income

https://pharmaphorum.com/news/cancer-research-uk-cuts-funding-as-covid-19-hits-income/

News

Call for mandatory disclosure of industry funding of patient groups

Richard Staines Funding, patient groups 0 Comment

Experts have warned that few patient groups have formal policies governing corporate funding and financial transparency, despite widespread

Call for mandatory disclosure of industry funding of patient groups

https://pharmaphorum.com/news/call-for-mandatory-disclosure-of-industry-funding-of-patient-groups/

Trending

Funding

Login